This was a real beat, not just a favorable earnings headline. Q2 revenue of $305.6 million exceeded the published consensus of about $292.0 million by roughly $13.6 million, while diluted EPS of $0.39 topped the $0.22 expectation. Sales grew 15.5%, ahead of the newly raised full-year growth range of 10%–12%, and the growth was volume-led: volume rose 15.7% while price/mix slipped 0.2%. That is a stronger demand signal than a price-driven beat. (Income Statement; Net Sales Bridge)
| Metric | Q2 2026 | Q2 2025 | Expectation / comparison |
|---|---|---|---|
| Net sales | $305.6M | $264.7M | Published consensus: ~$292.0M |
| Diluted EPS | $0.39 | $0.33 | Published consensus: ~$0.22 |
| Gross margin | 42.1% | 40.9% | +120 bps year over year |
| Adjusted gross margin | 48.6% | 46.9% | +170 bps year over year |
| Adjusted EBITDA | $52.2M | $44.4M | +17.6% year over year |
| Adjusted EBITDA margin | 17.1% | 16.8% | +30 bps year over year |
| FY 2026 sales-growth outlook | 10%–12% | — | Raised from 8%–11% |
| FY 2026 adjusted EBITDA outlook | $210M–$220M | — | Raised from $205M–$215M |
The outlook upgrade makes the quarter more consequential. Management raised both 2026 sales growth and adjusted EBITDA guidance rather than merely reporting a one-quarter upside surprise. The new midpoint implies $10 million more adjusted EBITDA than the prior outlook, while capital-spending guidance remains about $150 million. That says the company sees enough continuation in volume and operating improvement to lift profit expectations despite citing consumer uncertainty and cost inflation. (FY 2026 Guidance)
Margins improved, but the operating leverage was modest below gross profit. Lower input costs and better plant-cost absorption lifted adjusted gross margin by 170 basis points. However, adjusted SG&A rose to 31.4% of sales from 30.1%, principally reflecting higher logistics costs and variable compensation; adjusted EBITDA margin therefore expanded only 30 basis points. In plain terms: production economics improved meaningfully, but a sizable portion was absorbed by costs to distribute and run the business. (Adjusted Gross Profit Reconciliation; Adjusted SG&A Reconciliation; Adjusted EBITDA Reconciliation)
The EPS beat has a non-operating assist, though underlying profitability also improved. Q2 net income included a $4.5 million gain from post-closing adjustments on the previously sold equity investment. Excluding that item, the reported adjusted EBITDA still rose $7.8 million year over year to $52.2 million, so the positive read is not dependent on the investment gain—but the GAAP EPS beat is somewhat flattered by it. (Income Statement; Adjusted EBITDA Reconciliation)
Cash generation and buybacks add support, but liquidity is not net-cash. First-half free cash flow turned positive at $27.4 million versus a $21.2 million outflow a year earlier, and operating cash flow more than doubled to $84.8 million. Cash reached $350.8 million after nearly $100.0 million of investment-sale proceeds, while the company spent $54.4 million on repurchases; convertible notes remained $398.4 million. The balance sheet is more flexible, but the cash increase was not solely generated by operations. (Cash Flow Statement; Balance Sheet; Free Cash Flow Reconciliation)
Read the original 8-K on SEC EDGAR ↗